U.S. flag

An official website of the United States government

NM_001104631.2(PDE4D):c.677T>C (p.Phe226Ser) AND Acrodysostosis 2 with or without hormone resistance

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Apr 6, 2012
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000022936.5

Allele description [Variation Report for NM_001104631.2(PDE4D):c.677T>C (p.Phe226Ser)]

NM_001104631.2(PDE4D):c.677T>C (p.Phe226Ser)

Gene:
PDE4D:phosphodiesterase 4D [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
5q11.2
Genomic location:
Preferred name:
NM_001104631.2(PDE4D):c.677T>C (p.Phe226Ser)
HGVS:
  • NC_000005.10:g.59193507A>G
  • NG_027957.2:g.1335823T>C
  • NM_001104631.2:c.677T>CMANE SELECT
  • NM_001165899.2:c.494T>C
  • NM_001197218.2:c.485T>C
  • NM_001197219.2:c.311T>C
  • NM_001197220.2:c.287T>C
  • NM_001349241.2:c.464T>C
  • NM_001349242.2:c.347T>C
  • NM_001349243.2:c.-18T>C
  • NM_001364599.1:c.494T>C
  • NM_001364600.2:c.494T>C
  • NM_001364602.2:c.485T>C
  • NM_001364603.1:c.-274T>C
  • NM_001364604.1:c.-18T>C
  • NM_006203.5:c.269T>C
  • NP_001098101.1:p.Phe226Ser
  • NP_001159371.1:p.Phe165Ser
  • NP_001184147.1:p.Phe162Ser
  • NP_001184148.1:p.Phe104Ser
  • NP_001184149.1:p.Phe96Ser
  • NP_001336170.1:p.Phe155Ser
  • NP_001336171.1:p.Phe116Ser
  • NP_001351528.1:p.Phe165Ser
  • NP_001351529.1:p.Phe165Ser
  • NP_001351531.1:p.Phe162Ser
  • NP_006194.2:p.Phe90Ser
  • NC_000005.9:g.58489333A>G
Protein change:
F104S; PHE226SER
Links:
OMIM: 600129.0002; dbSNP: rs397514465
NCBI 1000 Genomes Browser:
rs397514465
Molecular consequence:
  • NM_001349243.2:c.-18T>C - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001364603.1:c.-274T>C - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001364604.1:c.-18T>C - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001104631.2:c.677T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001165899.2:c.494T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001197218.2:c.485T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001197219.2:c.311T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001197220.2:c.287T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001349241.2:c.464T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001349242.2:c.347T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001364599.1:c.494T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001364600.2:c.494T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001364602.2:c.485T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_006203.5:c.269T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Acrodysostosis 2 with or without hormone resistance
Synonyms:
ACRODYSOSTOSIS 2 WITH HORMONE RESISTANCE; ACRODYSOSTOSIS 2 WITHOUT HORMONE RESISTANCE
Identifiers:
MONDO: MONDO:0013822; MedGen: C3553250; Orphanet: 280651; OMIM: 614613

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000044227OMIM
no assertion criteria provided
Pathogenic
(Apr 6, 2012)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Exome sequencing identifies PDE4D mutations as another cause of acrodysostosis.

Michot C, Le Goff C, Goldenberg A, Abhyankar A, Klein C, Kinning E, Guerrot AM, Flahaut P, Duncombe A, Baujat G, Lyonnet S, Thalassinos C, Nitschke P, Casanova JL, Le Merrer M, Munnich A, Cormier-Daire V.

Am J Hum Genet. 2012 Apr 6;90(4):740-5. doi: 10.1016/j.ajhg.2012.03.003. Epub 2012 Mar 29.

PubMed [citation]
PMID:
22464250
PMCID:
PMC3322219

Details of each submission

From OMIM, SCV000044227.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In a 4-year-old boy with acrodysostosis-2 without hormone resistance (ACRDYS2; 614613), Michot et al. (2012) identified a de novo heterozygous 677T-C transition in the PDE4D gene, resulting in a phe226-to-ser (F226S) substitution in a conserved residue. The mutation was identified by exome sequencing and confirmed by Sanger sequencing; it was not found in 200 controls. The patient had advanced bone age, facial dysostosis with nasal hypoplasia and depressed nasal bridge, severe brachydactyly with short metacarpals, metatarsals, and phalanges, and cone-shaped epiphyses. He did not have signs of hormone resistance. He had intellectual disability with speech delay, as well as impairment of fine motor skills.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 10, 2024